Home » BIOALLIANCE PHARMA FILES FOR EUR30M IPO ON EURONEXT IN PARIS
BIOALLIANCE PHARMA FILES FOR EUR30M IPO ON EURONEXT IN PARIS
BioAlliance Pharma SA launched an IPO on Eurolist Compartment C of the Euronext
stock exchange in Paris with the aim of raising ⁈29.5 to ⁈33.8 million
and, in the words of its chairman and co-founder, Dominique Costantini, of "transmuting
from a drug discovery company into a profitable pharmaceutical company."
BioWorld
Today
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May